Pharmaceutical Compliance Consulting in Kingdom of Saudi Arabia
PHARPRO delivers CSV validation, QA gap assessments, CQV, thermal mapping, and GMP training for pharmaceutical companies in Kingdom of Saudi Arabia - remotely and on-site. Aligned with Saudi Food & Drug Authority (SFDA).
Understanding the KSA Pharmaceutical Landscape
Saudi Arabia has one of the largest pharmaceutical markets in the Middle East, driven by Vision 2030 healthcare investments and an expanding domestic manufacturing base. The Saudi Food and Drug Authority (SFDA) applies rigorous GMP inspection standards closely aligned with EU GMP and PIC/S, with an increasing focus on data integrity, CSV, and quality system maturity.
PHARPRO has worked with pharmaceutical clients across Kingdom of Saudi Arabia - both remotely and on-site - delivering CSV validation, QA support, and GMP training that meets the regulatory expectations your team faces.
Compliance Services for KSA Pharma
Remote and on-site support, delivered at the pace your programme requires.
CSV Validation
Full-lifecycle CSV for pharma software and laboratory systems. IQ/OQ/PQ, URS, risk classification, and audit trail review - aligned with EU GMP Annex 11 and FDA 21 CFR Part 11.
QA & Gap Assessment
Gap assessments against Saudi Food & Drug Authority (SFDA) and international GMP standards. SOP reviews, CAPA management, and data integrity programmes.
CQV & Thermal Mapping
Equipment and utility qualification (IQ/OQ/PQ) and temperature mapping studies for KSA pharmaceutical warehouses, cold chain facilities, and manufacturing areas.
GMP Training
Customised GMP training for KSA pharma teams - data integrity, CSV fundamentals, IQ/OQ/PQ methodology, and inspection readiness.
Inspection Readiness
Mock audits and gap assessments to prepare your KSA site for Saudi Food & Drug Authority (SFDA) inspections and international authority audits.
CAPA Management
Root cause analysis, corrective and preventive action planning, and CAPA effectiveness checks - aligned with ICH Q10 and GMP requirements.
Regulations We Work Within in KSA
All PHARPRO work in Kingdom of Saudi Arabia is aligned with applicable local and international regulatory standards.
Frequently Asked Questions - KSA
Yes. PHARPRO serves pharmaceutical manufacturers, distributors, and contract organisations across Kingdom of Saudi Arabia - both remotely and on-site. We have supported KSA clients with CSV validation, QA gap assessments, GMP training, and inspection readiness.
Pharmaceutical companies in Kingdom of Saudi Arabia must comply with Saudi Food & Drug Authority (SFDA) requirements, which are closely aligned with Saudi Food & Drug Authority (SFDA) GMP Guidelines, SFDA Drug Sector Regulatory Requirements, PIC/S GMP Guidelines (adopted by SFDA). Export-focused manufacturers must additionally comply with the regulatory requirements of their target markets.
Yes. PHARPRO delivers CSV documentation, QA assessments, gap analyses, and training programmes remotely with no loss in quality. For on-site work such as thermal mapping, facility walkthroughs, or mock inspections, our consultants travel to Kingdom of Saudi Arabia.
For urgent situations - imminent inspection or regulatory finding - PHARPRO can begin remote work within 3–5 business days. For planned projects, the typical kickoff is 1–2 weeks after proposal agreement.
Ready to start your KSA compliance project?
Start with a free 30-minute compliance assessment. No commitment, no sales pitch.